Prometheus Biosciences's total assets for Q were $754.71M, an increase of 1.88% from the previous quarter. RXDX total liabilities were $60.80M for the fiscal quarter, a -6.18% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.